| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/BJH.12031 |
| P8608 | Fatcat ID | release_jm73asldznfavnncsy3y7viegi |
| P932 | PMC publication ID | 7161751 |
| P698 | PubMed publication ID | 22924410 |
| P5875 | ResearchGate publication ID | 230746487 |
| P2093 | author name string | Roger Y Dodd | |
| P2860 | cites work | RETRACTED: Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant | Q21090538 |
| A single mutation in chikungunya virus affects vector specificity and epidemic potential | Q21131599 | ||
| Emerging infections: a perpetual challenge | Q24514431 | ||
| Retraction for Lo et al., Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors | Q24613575 | ||
| Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors | Q24613662 | ||
| Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study | Q24619233 | ||
| The Chikungunya epidemic in Italy and its repercussion on the blood system | Q27487584 | ||
| Microbe Hunting | Q27890382 | ||
| Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome | Q28260932 | ||
| Human babesiosis | Q28269239 | ||
| Dengue | Q29619772 | ||
| Social and environmental risk factors in the emergence of infectious diseases | Q30977705 | ||
| Reduction of transmissible spongiform encephalopathy infectivity from human red blood cells with prion protein affinity ligands | Q33249911 | ||
| Review of dengue fever cases in Hong Kong during 1998 to 2005. | Q33379846 | ||
| First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features | Q33875443 | ||
| Chikungunya outbreaks--the globalization of vectorborne diseases | Q34002554 | ||
| Transfusion transmission of highly prevalent commensal human viruses | Q34117179 | ||
| Transfusion-associated babesiosis in the United States: a description of cases | Q34213698 | ||
| Parvovirus B19. | Q34294811 | ||
| Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti | Q34491565 | ||
| A new arenavirus in a cluster of fatal transplant-associated diseases | Q34747133 | ||
| Emerging infectious disease agents and their potential threat to transfusion safety | Q34997865 | ||
| Recombinant origin of the retrovirus XMRV. | Q35755248 | ||
| Natural history and pathophysiology of Q fever | Q36081084 | ||
| Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease | Q36497719 | ||
| Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study | Q36588347 | ||
| Modern plasma fractionation | Q36775707 | ||
| Trypanosoma cruzi infection in North America and Spain: evidence in support of transfusion transmission | Q37982844 | ||
| Review: Creutzfeldt-Jakob disease: prion protein type, disease phenotype and agent strain. | Q37990996 | ||
| Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico | Q40296125 | ||
| Coxiella burnetii infection among blood donors during the 2009 Q-fever outbreak in The Netherlands. | Q40318444 | ||
| Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion | Q40393933 | ||
| West Nile virus among blood donors in the United States, 2003 and 2004. | Q40502172 | ||
| Westward ho?--The spread of West Nile virus | Q40520344 | ||
| Transmission of West Nile Virus through Blood Transfusion in the United States in 2002 | Q40550030 | ||
| Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City | Q40572754 | ||
| Dengue hemorrhagic fever transmitted by blood transfusion | Q42981989 | ||
| West Nile virus infection transmitted by granulocyte transfusion | Q43037151 | ||
| Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. | Q43220367 | ||
| Estimated risk of Chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005 to 2007. | Q44140323 | ||
| Xenotropic murine leukemia virus-related virus does not pose a risk to blood recipient safety | Q44457028 | ||
| A nationwide survey for hepatitis E virus prevalence in Japanese blood donors with elevated alanine aminotransferase | Q45391273 | ||
| The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. | Q45936364 | ||
| Human babesiosis in New York State: Review of 139 hospitalized cases and analysis of prognostic factors. | Q50859211 | ||
| Clearance of prions during plasma protein manufacture. | Q53607396 | ||
| Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program. | Q54317268 | ||
| Retraction | Q55922337 | ||
| Severe acute respiratory syndrome | Q56775278 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | emerging pathogen | Q108429945 |
| P304 | page(s) | 135-142 | |
| P577 | publication date | 2012-08-28 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | Emerging pathogens and their implications for the blood supply and transfusion transmitted infections | |
| P478 | volume | 159 |
| Q40662421 | A consensus-based tool for ranking the risk of blood-transmissible infections |
| Q33420777 | Bitten by a bug or a bag? Transfusion-transmitted dengue: a rare complication in the bleeding surgical patient |
| Q44102123 | Blood-Borne Pathogens: A Canadian Blood Services Centre for Innovation Symposium. |
| Q26775412 | Convalescent plasma: new evidence for an old therapeutic tool? |
| Q93223160 | Current status of potential therapeutic candidates for the COVID-19 crisis |
| Q29365382 | Decision making in the face of uncertainty: the challenge of emerging infectious diseases |
| Q30369241 | Ebola virus convalescent blood products: where we are now and where we may need to go. |
| Q43047264 | Emerging infectious disease outbreaks: estimating disease risk in Australian blood donors travelling overseas |
| Q41201448 | Evaluation of the effectiveness of a pathogen inactivation technology against clinically relevant transfusion-transmitted bacterial strains |
| Q53251240 | Functional characteristics and clinical effectiveness of platelet concentrates treated with riboflavin and ultraviolet light in plasma and in platelet additive solution. |
| Q26777044 | Hepatitis E virus infection: Epidemiology and treatment implications |
| Q26775408 | Improving platelet transfusion safety: biomedical and technical considerations |
| Q99727888 | Metagenomic analysis and identification of emerging pathogens in blood from healthy donors |
| Q46141738 | Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion. |
| Q28655769 | Pathogen inactivation technologies for cellular blood components: an update |
| Q21245484 | Pathogen-free, plasma-poor platelet lysate and expansion of human mesenchymal stem cells |
| Q33443256 | Preparation of Platelet Concentrates for Research and Transfusion Purposes |
| Q38220202 | Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion |
| Q39150151 | Prioritizing of bacterial infections transmitted through substances of human origin in Europe. |
| Q38194595 | Red blood cell transfusions for thalassemia: results of a survey assessing current practice and proposal of evidence-based guidelines |
| Q52661549 | Reflections on Dry Eye Syndrome Treatment: Therapeutic Role of Blood Products. |
| Q30881753 | Seroprevalence of Antibodies to Ross River and Barmah Forest Viruses: Possible Implications for Blood Transfusion Safety After Extreme Weather Events |
| Q24282614 | Solvent/Detergent Virally Inactivated Serum Eye Drops Restore Healthy Ocular Epithelium in a Rabbit Model of Dry-Eye Syndrome |
| Q35394095 | The effect of riboflavin and ultraviolet light on the infectivity of arboviruses |
| Q29994506 | Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prospects for developing countries |
| Q50200336 | Transfusion-related immunomodulation: a reappraisal |
| Q38279968 | “Go no Go” in plasma fractionation in the world’s emerging economies: still a question asked 70 years after the COHN process was developed! |
Search more.